“cubist” Archives

in
Entry Author Date Location
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Ex-Cubist CEO Bonney Emerges at Kaleido, Flagship’s Latest Microbiome Startup 09/18/17 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
Boston’s Life Science Disruptors: The Photos 10/07/13 Boston
San Diego Life Sciences News: Trius, Optimer, aTyr, Ligand, and More 08/01/13 San Diego
Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program” 10/26/11 Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence 05/26/11 Boston
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News 04/07/11 San Diego
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market 05/11/10 Boston
Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy 07/08/09 Seattle
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections 01/09/09 Boston
Page 1 of 1